Skip to main content
Clinical Trials/KCT0008816
KCT0008816
Completed
未知

Pilot Study to prove the reproducibility of the intestinal environment of PMAS(Pharmaceutical Meta-Analytical Screening) System through the production of Equol after intake of Soy Isoflavone

HEM Pharma0 sites36 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
HEM Pharma
Enrollment
36
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 10, 2023
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
HEM Pharma

Eligibility Criteria

Inclusion Criteria

  • 1\. Healthy adults who are 19 years of age or older.
  • 2\. Individuals who have willingly and voluntarily agreed to participate in this study.

Exclusion Criteria

  • 1\. Individuals who have a hypersensitivity or allergy to soy materials, such as soy isoflavones.
  • 2\. Individuals who have been determined by the tester to be unsuitable for participation in the human application test.
  • 3\. Individuals who have used systemic antibiotics within one week prior to Visit 1\.
  • 4\. Pregnant and lactating women.

Outcomes

Primary Outcomes

Not specified

Similar Trials